SAB Biotherapeutics, Inc. - SABS

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 27
Latest filed: Mar 25, 2026
Form Count
4 15
8-K 5
SCHEDULE 13G/A 3
SCHEDULE 13D/A 2
SCHEDULE 13G 2

Latest files

Filed Form Report period Accession SEC
Mar 25, 2026 4 Mar 24, 2026 0001193125-26-124231 View
Mar 23, 2026 SCHEDULE 13D/A 0001346824-26-000079 View
Mar 19, 2026 8-K Mar 17, 2026 0001193125-26-114730 View
Mar 11, 2026 SCHEDULE 13D/A 0001346824-26-000072 View
Mar 10, 2026 8-K Mar 10, 2026 0001193125-26-099376 View
Feb 17, 2026 SCHEDULE 13G/A 0001493215-26-000048 View
Feb 17, 2026 SCHEDULE 13G/A 0000921895-26-000472 View
Feb 05, 2026 4 Feb 03, 2026 0001193125-26-039508 View
Feb 05, 2026 4 Feb 03, 2026 0001193125-26-039524 View
Feb 05, 2026 4 Feb 03, 2026 0001193125-26-039537 View
Feb 05, 2026 4 Feb 05, 2026 0001193125-26-039564 View
Feb 05, 2026 4 Feb 03, 2026 0001193125-26-039577 View
Jan 22, 2026 SCHEDULE 13G 0001193125-26-019535 View
Jan 12, 2026 8-K Jan 12, 2026 0001193125-26-010515 View
Jan 07, 2026 8-K Jan 05, 2026 0001193125-26-005487 View
Jan 07, 2026 4 Jan 05, 2026 0001193125-26-006427 View
Jan 07, 2026 4 Jan 05, 2026 0001193125-26-006435 View
Dec 29, 2025 8-K Dec 29, 2025 0001193125-25-335267 View
Dec 18, 2025 4 Dec 16, 2025 0001193125-25-324963 View
Dec 18, 2025 4 Dec 16, 2025 0001193125-25-324970 View
Dec 18, 2025 4 Dec 16, 2025 0001193125-25-324976 View
Dec 18, 2025 4 Dec 16, 2025 0001193125-25-324991 View
Dec 18, 2025 4 Dec 16, 2025 0001193125-25-325002 View
Dec 18, 2025 4 Dec 16, 2025 0001193125-25-325007 View
Dec 12, 2025 4 Dec 11, 2025 0001193125-25-317688 View
Nov 14, 2025 SCHEDULE 13G 0000902664-25-005039 View
Nov 14, 2025 SCHEDULE 13G/A 0000921895-25-003116 View